Monitor integration of FLUENT's Florida operations and the pending sales of New York and Texas assets for cash proceeds. Watch for any further stake increases by Chicago Atlantic, which now holds 11.7% and may acquire additional shares in a proposed Ohio acquisition.
Price Chart
How similar events traded
Executive Summary
Vireo Growth Inc. completed its acquisition of FLUENT Corp. on November 9, 2026, issuing 6,148,780 Vireo Shares as consideration. Concurrently, FLUENT equitized approximately $35.7 million of senior debt into shares that were exchanged for 4,729,326 Vireo Shares (Lender Exchange Shares), increasing Chicago Atlantic's beneficial ownership from 6.2% to 11.7% of Vireo. The deal expands Vireo's Florida footprint to ~74 dispensaries and ~317,000 sq ft of cultivation capacity, while FLUENT's New York and Texas operations are slated for sale.
Key Facts
- Vireo issued 6,148,780 shares to acquire all FLUENT shares at an exchange ratio of 0.002351197 Vireo Shares per FLUENT Share
- FLUENT equitized ~$35.7M of senior debt into 2,011,455,727 FLUENT Shares, exchanged for 4,729,326 Vireo Lender Exchange Shares
- Chicago Atlantic's beneficial ownership rose from 6.2% to 11.7% of Vireo post-closing
- Vireo adds 33 FLUENT dispensaries and ~117,000 sq ft of cultivation, expanding to ~74 total dispensaries and ~317,000 sq ft in Florida
- FLUENT's New York (Etain, LLC) and Texas (Cansortium Texas, LLC) operations to be sold to third parties, subject to regulatory approvals
- Lender Exchange Shares are subject to a six-month lock-up
- CEO John Mazarakis is a partner of Chicago Atlantic Group, LP, an affiliate of Chicago Atlantic
Financial Impact
All-stock acquisition with no stated cash consideration; $35.7M of FLUENT debt equitized into Vireo shares; no purchase price or premium disclosed
Risk Factors
- Dilution from 6.15M new shares plus 4.73M Lender Exchange Shares, with Chicago Atlantic now at 11.7% ownership
- Related-party governance concerns as CEO Mazarakis is a Chicago Atlantic affiliate
- Pending asset sales in New York and Texas subject to regulatory approvals and may not close
- No financial statements or pro forma disclosures provided in this filing
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-128260 |
| Document: tm2629831d1_ex99-1.htm | 0001104659-26-128260 |
| Document: 0001104659-26-128260-index-headers.html | 0001104659-26-128260 |
| Document: 0001104659-26-128260-index.html | 0001104659-26-128260 |
| Document: 0001104659-26-128260.txt | 0001104659-26-128260 |
Track record
24 reports on VREOF
2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +18.71% at T+60 after the Jun 18, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 17, 2026today 8-K Neutral 3/10 Entry $6.31 Now $6.01 −4.75% settles Feb 17
- Nov 16, 20261d ago SC 13G Neutral 3/10 Entry $6.15 Now $6.01 −2.28% settles Feb 16
- Nov 16, 20261d ago 8-K Neutral 5/10 Viewing Entry $6.15 Now $6.01 −2.28% settles Feb 16
- Nov 13, 20264d ago 3 Neutral 3/10 Entry $6.13 Now $6.01 −1.89% settles Feb 11
- Nov 13, 20264d ago 3 Neutral 2/10 Entry $6.13 Now $6.01 −1.89% settles Feb 11
- Nov 10, 20267d ago SC 13D/A Neutral 4/10 Entry $6.74 Now $6.01 −10.83% settles Feb 9
- Nov 10, 20267d ago 8-K Neutral 5/10 Entry $6.68 Now $6.01 −10.03% settles Feb 8
- Nov 3, 202614d ago EFFECT Neutral 4/10 Entry $7.45 Now $6.01 −19.33% settles Feb 1
- Oct 30, 202618d ago S-4/A Neutral 5/10 Entry $7.36 Now $6.01 −18.34% settles Jan 29
- Oct 9, 20265w ago S-4 Neutral 5/10 Entry $9.15 Now $6.01 −34.30% settles Jan 7
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers